• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Hatteras Venture Partners

edit

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine.

Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.

Recent Milestones

edit

• 
  Hatteras Venture Partners invested in Coferon. (7/16/12)
  Posted 7/16/12 at 6:12pm via marketwire.com
• 
  Hatteras Venture Partners invested in PhaseBio Pharmaceuticals. (6/5/12)
  Posted 6/5/12 at 6:19pm via dowjones.com
• 
  Hatteras Venture Partners invested in SugarSync. (2/29/12)
  Posted 2/29/12 at 4:41am via techcrunch.com
• 
  Hatteras Venture Partners invested in GeneCentric Diagnostics. (1/20/12)
  Posted 1/20/12 at 3:06am via dowjones.com
• 
  Hatteras Venture Partners invested in Clearside Biomedical. (1/5/12)
  Posted 1/5/12 at 5:07am via newsobserver.com
• 
  Hatteras Venture Partners invested in Clinipace WorldWide. (9/27/11)
  Posted 9/27/11 at 6:15pm via finsmes.com
• 
  Hatteras Venture Partners invested in TetraLogic Pharmaceuticals. (8/10/10)
  Posted 8/10/10 at 5:26pm via fiercebiotech.com
• 
  Hatteras Venture Partners invested in Anulex. (6/7/10)
  Posted 6/7/10 at 8:44pm via onbiovc.com
• 
  Hatteras Venture Partners invested in PhaseBio Pharmaceuticals. (1/7/10)
  Posted 1/7/10 at 8:35pm via finsmes.com
• 
  Hatteras Venture Partners invested in Viamet Pharmaceuticals. (7/7/09)
  Posted 9/24/09 at 3:07pm via fiercebiotech.com
• 
  Hatteras Venture Partners invested in ArtusLabs. (6/26/08)
  Posted 5/21/09 at 9:43pm via ncbiotech.org
• 
  Hatteras Venture Partners invested in SpineAlign Medical. (6/3/08)
  Posted 9/17/09 at 4:36am via venturebeat.com
• 
  Hatteras Venture Partners invested in PhaseBio Pharmaceuticals. (10/24/07)
  Posted 3/16/10 at 1:35am via duke.edu
• 
  Hatteras Venture Partners invested in Viamet Pharmaceuticals. (6/7/07)
  Posted 3/17/10 at 2:59am via findarticles.com

Investments

Videos

Sources

1. Hatteras Venture Partners Closes Fourth Fund at $125M (finsmes.com) [edit]
2. Coferon, Inc. Announces $12 Million Series B Financing (marketwire.com) [edit]
3. PhaseBio Pharmaceuticals Books $23M in Third Tranche of Series B (pevc.dowjones.com) [edit]
4. Cloud-Based File Syncing Platform SugarSync Raises $15M To Add Another Data Center To The Mix (techcrunch.com) [edit]
5. GeneCentric Takes Seed Funds From Hatteras For Lung Cancer Test (fis.dowjones.com) [edit]
6. Clearside raises $4 million to advance its eye treatment (newsobserver.com) [edit]
7. Clinipace Worldwide Closes $15M Series C Funding Round (finsmes.com) [edit]
8. TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy (fiercebiotech.com) [edit]
9. Anulex Technologies, Inc.: Series E $18.3M (onbiovc.com) [edit]
10. PhaseBio Pharmaceuticals Raises $25M in Series B Funding Round (finsmes.com) [edit]
11. Viamet gets Big Pharma support in $18M round Read more: http://www.fiercebiotech.com/story/viamet-gets-big-pharma-support-18m-round/2009-07-07#ixzz0S4Hjz62O (fiercebiotech.com) [edit]
12. Durham's ArtusLabs Lands $2.6M in Venture Funding (ncbiotech.org) [edit]
13. Spineworks Medical raising $8.8M for spinal devices (deals.venturebeat.com) [edit]
14. Phase Bioscience raises $6.6 million (olv.duke.edu) [edit]
15. Viamet Pharmaceuticals Raises $4 Million Round of Financing (findarticles.com) [edit]